![](https://images.aatbio.com/dataset/ic50/platelet-derived-growth-factor-receptor-alpha_b2d54f313fd6fae3559ad99a1d264705.svg) | Imatinib | IC50 | 18.0 [1] |
![](https://images.aatbio.com/dataset/ic50/platelet-derived-growth-factor-receptor-alpha_8edb893ba88c5700603edef201da4265.svg) | Nintedanib | IC50 | 1.9 [1], 2.3 [2], 4.0 [3], 18.0 [4], 59.0 [5] |
![](https://images.aatbio.com/dataset/ic50/platelet-derived-growth-factor-receptor-alpha_1d5eba4b4bb57896dda18b1604bab021.svg) | Staurosporine | IC50 | 0.1 [1], 0.43 [2], 0.45 [3], 0.6 [4] |
![](https://images.aatbio.com/dataset/ic50/platelet-derived-growth-factor-receptor-alpha_173905a1d8206fe6271a8ee9486c99d9.svg) | Foretinib | IC50 | 3.6 [1], 6.82 [2] |
![](https://images.aatbio.com/dataset/ic50/platelet-derived-growth-factor-receptor-alpha_fd951065be8c84c1b332e18593d47262.svg) | N-(1,3-Benzodioxol-5-ylmethyl)-4-(6,7-dimethoxyquinazolin-4-yl)piperazine-1-carbothioamide | IC50 | 210.0 [1], 25000.0 [2], 26600.0 [3] |
![](https://images.aatbio.com/dataset/ic50/platelet-derived-growth-factor-receptor-alpha_afa50af73945215efffef3467eacb5de.svg) | Imatinib mesylate | IC50 | 20000.0 [1], 24000.0 [2] |
![](https://images.aatbio.com/dataset/ic50/platelet-derived-growth-factor-receptor-alpha_986db0437f20070dfb14143a9f1b018d.svg) | Dasatinib | IC50 | 9.9 [1], 63.0 [2] |
![](https://images.aatbio.com/dataset/ic50/platelet-derived-growth-factor-receptor-alpha_f59214b920b0faf58103b7de887f46c7.svg) | Nilotinib | IC50 | 2.54 [1], 71.0 [2] |
![](https://images.aatbio.com/dataset/ic50/platelet-derived-growth-factor-receptor-alpha_b9bd2d98b11bb07c7703bd6ad3510bbb.svg) | Amuvatinib | IC50 | 2100.0 [1], 3000.0 [2] |
![](https://images.aatbio.com/dataset/ic50/platelet-derived-growth-factor-receptor-alpha_8030213d9f30efd3da30350a03e56f0d.svg) | PDGF Receptor Tyrosine Kinase Inhibitor IV | IC50 | 45.0 [1] |
![](https://images.aatbio.com/dataset/ic50/platelet-derived-growth-factor-receptor-alpha_95b1b6a854f1ad22b69c67dae323c503.svg) | 4-(6,7-Dimethoxy-9H-pyrimido[4,5-b]indol-4-yl)-N-[4-(pyrimidin-2-ylsulfamoyl)phenyl]piperazine-1-carbothioamide | IC50 | 50000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/platelet-derived-growth-factor-receptor-alpha_056aae54a9b0570d9f31dd2c1e76aa8d.svg) | (4S,6Z)-18-Hydroxy-16-methoxy-4-methyl-3-oxabicyclo[12.4.0]octadeca-1(14),6,15,17-tetraene-2,8-dione | IC50 | 95.0 [1], 440.0 [2] |
![](https://images.aatbio.com/dataset/ic50/platelet-derived-growth-factor-receptor-alpha_bdd9b3ea8f8f27f7769808b33b9481ce.svg) | 1-(2,2-Diethoxyethyl)-3-(1H-pyrrolo[2,3-b]pyridin-5-yl)pyrazolo[3,4-d]pyrimidin-4-amine | IC50 | 10000.0 [1], 100000.0 [2] |
![](https://images.aatbio.com/dataset/ic50/platelet-derived-growth-factor-receptor-alpha_ed54163abaedf6f16a85ab07bbd0f764.svg) | N-[[4-(6,7-Dimethoxyquinolin-4-yl)oxyphenyl]carbamoyl]-2-methylbenzamide | IC50 | 4.0 [1], 7.6 [2] |
![](https://images.aatbio.com/dataset/ic50/platelet-derived-growth-factor-receptor-alpha_00702ce6469a72c9dd1c3bc8ee377618.svg) | 4-(4-(5-Benzylpyrimidin-2-yl)piperazin-1-yl)quinazoline | IC50 | 295.0 [1], 316.0 [2] |
![](https://images.aatbio.com/dataset/ic50/platelet-derived-growth-factor-receptor-alpha_a840767d7ddb2c27c40164419a996160.svg) | Infigratinib phosphate | IC50 | 2718.0 [1], 10000.0 [2] |
![](https://images.aatbio.com/dataset/ic50/platelet-derived-growth-factor-receptor-alpha_4c1c8e479c2e24660577929dfcea7599.svg) | 1-[4-[3-[4-Amino-5-[2-fluoro-5-[[(2S)-oxolan-2-yl]methoxy]phenyl]pyrrolo[2,3-d]pyrimidin-7-yl]cyclobutyl]piperazin-1-yl]ethanone | IC50 | 5300.0 [1], 10000.0 [2] |
![](https://images.aatbio.com/dataset/ic50/platelet-derived-growth-factor-receptor-alpha_05bff60f7acf19e2603925e4914ecd1c.svg) | N-(1,3-Benzodioxol-5-ylmethyl)-4-(6,7-dimethoxy-9H-pyrimido[4,5-b]indol-4-yl)piperazine-1-carbothioamide | IC50 | 15500.0 [1], 16000.0 [2] |
![](https://images.aatbio.com/dataset/ic50/platelet-derived-growth-factor-receptor-alpha_86e81180f8060ae99cc97a45a22e8085.svg) | N-(1,3-Benzodioxol-5-ylmethyl)-4-(8-thia-3,5,10-triazatricyclo[7.4.0.02,7]trideca-1(9),2(7),3,5,10,12-hexaen-6-yl)piperazine-1-carbothioamide | IC50 | 50000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/platelet-derived-growth-factor-receptor-alpha_a9369941e4d4b47feeac2b70bfb1bbb2.svg) | Amuvatinib hydrochloride | IC50 | 40.0 [1], 81.0 [2] |
![](https://images.aatbio.com/dataset/ic50/platelet-derived-growth-factor-receptor-alpha_771414ca4180651b8ea0d4ad4af039a4.svg) | N-[4-(Pyrimidin-2-ylsulfamoyl)phenyl]-4-(8-thia-3,5,10-triazatricyclo[7.4.0.02,7]trideca-1(9),2(7),3,5,10,12-hexaen-6-yl)piperazine-1-carbothioamide | IC50 | 50000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/platelet-derived-growth-factor-receptor-alpha_2c71537b0d97471e12d6efbc8935980c.svg) | 4-(6,7-Dimethoxyquinazolin-4-yl)-N-[4-(pyrimidin-2-ylsulfamoyl)phenyl]piperazine-1-carbothioamide | IC50 | 50000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/platelet-derived-growth-factor-receptor-alpha_7de5848be93196a6906eba944a298431.svg) | Sunitinib | IC50 | 130.0 [1] |
![](https://images.aatbio.com/dataset/ic50/platelet-derived-growth-factor-receptor-alpha_755000a88f2651809d912de0f446bcfe.svg) | Lapatinib | IC50 | 20000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/platelet-derived-growth-factor-receptor-alpha_c77eb69f87d46b4d00314a6bfb851cf8.svg) | Crizotinib | IC50 | 1000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/platelet-derived-growth-factor-receptor-alpha_1c0dbc70a65a3eccf3e39ecce75f7f37.svg) | Pazopanib | IC50 | 71.0 [1] |
![](https://images.aatbio.com/dataset/ic50/platelet-derived-growth-factor-receptor-alpha_12fa190f2d2e4b2561e24185e6a9c597.svg) | Nintedanib esylate | IC50 | 59.0 [1] |
![](https://images.aatbio.com/dataset/ic50/platelet-derived-growth-factor-receptor-alpha_8a69b3902a36c5bcb114db8f49f8eabe.svg) | Semaxanib | IC50 | 200.0 [1] |
![](https://images.aatbio.com/dataset/ic50/platelet-derived-growth-factor-receptor-alpha_34ec291e290db2e13648ccc8dee7e3a5.svg) | Cabozantinib | IC50 | 10000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/platelet-derived-growth-factor-receptor-alpha_4e9df3bd1ea0920231ce5d4b41666b94.svg) | Ponatinib | IC50 | 2.6 [1] |
![](https://images.aatbio.com/dataset/ic50/platelet-derived-growth-factor-receptor-alpha_295456cbf7462dfb1eaccb88d6610904.svg) | Ceritinib | IC50 | 1140.0 [1] |
![](https://images.aatbio.com/dataset/ic50/platelet-derived-growth-factor-receptor-alpha_86afa169fbf5024375ee5d399dedddf5.svg) | Saracatinib | IC50 | 10000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/platelet-derived-growth-factor-receptor-alpha_0a83b01cf93719a90ccaeda771089c43.svg) | Doramapimod | IC50 | 30000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/platelet-derived-growth-factor-receptor-alpha_bb4cc4ba12c445644d4d7e378c81bf86.svg) | Elliptinium | IC50 | 700.0 [1] |
![](https://images.aatbio.com/dataset/ic50/platelet-derived-growth-factor-receptor-alpha_a257c791d1de1df5d4a1fa04612f9c76.svg) | Nvp-aew541 | IC50 | 800.0 [1] |
![](https://images.aatbio.com/dataset/ic50/platelet-derived-growth-factor-receptor-alpha_b31b26bc40d5af9014ccf8818a8bb4df.svg) | 9-Hydroxyellipticine | IC50 | 600.0 [1] |
![](https://images.aatbio.com/dataset/ic50/platelet-derived-growth-factor-receptor-alpha_4e38800d1c310079b3b3e65c5db78d0d.svg) | Linifanib | IC50 | 15.0 [1] |
![](https://images.aatbio.com/dataset/ic50/platelet-derived-growth-factor-receptor-alpha_ae3c621c3ca0049e7a4045efa2e650e7.svg) | Tivozanib | IC50 | 2.26 [1] |
![](https://images.aatbio.com/dataset/ic50/platelet-derived-growth-factor-receptor-alpha_def2622457c2392ae7d83708b0039226.svg) | 4-[[9-Chloro-7-(2,6-difluorophenyl)-5H-pyrimido[5,4-d][2]benzazepin-2-yl]amino]benzoic acid | IC50 | 794.33 [1] |
![](https://images.aatbio.com/dataset/ic50/platelet-derived-growth-factor-receptor-alpha_e7ecb06887875f4d78baf892d82c33a5.svg) | Bms-777607 | IC50 | 28.0 [1] |
![](https://images.aatbio.com/dataset/ic50/platelet-derived-growth-factor-receptor-alpha_fa37ae125bcd4e6df1af4be57fbea491.svg) | 1-Cyclopropyl-3-(3-(5-(morpholinomethyl)-1H-benzo[d]imidazol-2-yl)-1H-pyrazol-4-yl)urea | IC50 | 10.0 [1] |
![](https://images.aatbio.com/dataset/ic50/platelet-derived-growth-factor-receptor-alpha_21b312da3a0ca2e00016eafda80097df.svg) | Bemcentinib | IC50 | 20.0 [1] |
![](https://images.aatbio.com/dataset/ic50/platelet-derived-growth-factor-receptor-alpha_af49e826afb61d1f01ee3787f03fc143.svg) | 9H-Purine-2,6-diamine, N2-(2-aminocyclohexyl)-N6-(3-chlorophenyl)-9-ethyl-, cis- | IC50 | 20000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/platelet-derived-growth-factor-receptor-alpha_631afb47e853c43666053a2a26b2be01.svg) | 1-(Tert-Butyl)-3-(p-tolyl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine | IC50 | 657.0 [1] |
![](https://images.aatbio.com/dataset/ic50/platelet-derived-growth-factor-receptor-alpha_83c234bb8d1f466b89c0cd84a644d9f8.svg) | (E)-N-(5-Methyl-1H-pyrazol-3-yl)-6-(4-methylpiperazin-1-yl)-2-styrylpyrimidin-4-amine | IC50 | 56.0 [1] |
![](https://images.aatbio.com/dataset/ic50/platelet-derived-growth-factor-receptor-alpha_3b9e10412a2d6240147321cb2601cee1.svg) | VEGF receptor tyrosine kinase inhibitor III | IC50 | 970.0 [1] |
![](https://images.aatbio.com/dataset/ic50/platelet-derived-growth-factor-receptor-alpha_c74a1b9d6feb1def6b7e3f6834b5761b.svg) | Tak-285 | IC50 | 10000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/platelet-derived-growth-factor-receptor-alpha_f3d0fcadcce0816240114937491b30f7.svg) | 1-(2,4-Difluorophenyl)-3-(4-(6,7-dimethoxyquinolin-4-yloxy)-2-fluorophenyl)urea | IC50 | 67.0 [1] |
![](https://images.aatbio.com/dataset/ic50/platelet-derived-growth-factor-receptor-alpha_b63a2565bd4d512206a1c9679cacee61.svg) | 3-((4-Bromo-2,6-difluorobenzyl)oxy)-5-(3-(4-(pyrrolidin-1-yl)butyl)ureido)isothiazole-4-carboxamide | IC50 | 3120.0 [1] |
![](https://images.aatbio.com/dataset/ic50/platelet-derived-growth-factor-receptor-alpha_179888a64edb35ddee0be2a16e245b3a.svg) | MK-2461 | IC50 | 100.0 [1] |
![](https://images.aatbio.com/dataset/ic50/platelet-derived-growth-factor-receptor-alpha_27d3a5b4d06517b7e7f7d0e79a2b07e5.svg) | CID 44219749 | IC50 | 50000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/platelet-derived-growth-factor-receptor-alpha_fe739739798d5a426922dc4c74a41375.svg) | (4S,6Z,9S,10S)-9,10,18-Trihydroxy-16-methoxy-4-methyl-3-oxabicyclo[12.4.0]octadeca-1(14),6,15,17-tetraene-2,8-dione | IC50 | 2.38 [1] |
![](https://images.aatbio.com/dataset/ic50/platelet-derived-growth-factor-receptor-alpha_580efe2e66439369c377fd174fde96fb.svg) | Ilorasertib | Ki | 0.79 [1] |
![](https://images.aatbio.com/dataset/ic50/platelet-derived-growth-factor-receptor-alpha_f1099aa3bd39876799914a83803e440e.svg) | Tak-593 | IC50 | 4.3 [1] |
![](https://images.aatbio.com/dataset/ic50/platelet-derived-growth-factor-receptor-alpha_9b758bfffd41ecd8dbc5fd96a1378a28.svg) | CID 53246941 | IC50 | 956.0 [1] |
![](https://images.aatbio.com/dataset/ic50/platelet-derived-growth-factor-receptor-alpha_b2e0374192c14780687bb9ed1d5a397b.svg) | PDGF Receptor Tyrosine Kinase Inhibitor III | IC50 | 50.0 [1] |
![](https://images.aatbio.com/dataset/ic50/platelet-derived-growth-factor-receptor-alpha_ac9e30b723e2c9bf1debc2a45966acbb.svg) | 3-(1H-Indol-3-yl)-4-(3,4,5-trimethoxyphenyl)pyrrole-2,5-dione | IC50 | 943.0 [1] |
![](https://images.aatbio.com/dataset/ic50/platelet-derived-growth-factor-receptor-alpha_81451b6325bdc51ecc91d525cf1e5a78.svg) | Mivavotinib | IC50 | 45.0 [1] |
![](https://images.aatbio.com/dataset/ic50/platelet-derived-growth-factor-receptor-alpha_941408e43c25b505975eab00c707db56.svg) | 1-[2-Fluoro-4-(5-methylpyrrolo[3,2-d]pyrimidin-4-yl)oxyphenyl]-3-[3-(trifluoromethyl)phenyl]urea | IC50 | 35.0 [1] |
![](https://images.aatbio.com/dataset/ic50/platelet-derived-growth-factor-receptor-alpha_dd39a95211e2a7beed01f0aa58e3406a.svg) | Flt3-IN-1 | IC50 | 10000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/platelet-derived-growth-factor-receptor-alpha_15a4bcfb2ea319b026c020006e2b004c.svg) | Cep-11981 | IC50 | 246.0 [1] |
![](https://images.aatbio.com/dataset/ic50/platelet-derived-growth-factor-receptor-alpha_aa78cc3183c29821fe7c015c8320a3ff.svg) | CID 44814409 | IC50 | 10000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/platelet-derived-growth-factor-receptor-alpha_6d88b63d79f8227aaff5b373a75326db.svg) | 3-((4-(6-Methylpyridin-2-yl)-5-(quinolin-6-yl)-1H-imidazol-2-yl)methyl)benzamide | IC50 | 3000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/platelet-derived-growth-factor-receptor-alpha_6c77ec0d5dc9ee628942395e9056e052.svg) | 1-[4-(6,7-Dimethoxy-quinazolin-4-yloxy)-phenyl]-3-(4-methoxy-phenyl)-urea | IC50 | 3.6 [1] |
![](https://images.aatbio.com/dataset/ic50/platelet-derived-growth-factor-receptor-alpha_fd7143dda19bb3f4b870cb48393d13ab.svg) | (E)-1-(4-((6-Amino-5-((methoxyimino)methyl)pyrimidin-4-yl)oxy)-2-chlorophenyl)-3-ethylurea | IC50 | 1110.0 [1] |
![](https://images.aatbio.com/dataset/ic50/platelet-derived-growth-factor-receptor-alpha_e889c2ab861ba6e523222b876e4b9d6a.svg) | 4-[5-(6-Methoxynaphthalen-2-yl)-1-methyl-2-(2-methyl-4-methylsulfinylphenyl)imidazol-4-yl]pyridine | IC50 | 30000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/platelet-derived-growth-factor-receptor-alpha_c7ea91415258cf701a653bfc92e395ff.svg) | (5-Hydroxy-1H-indol-2-yl)-(1H-indol-2-yl)methanone | IC50 | 1000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/platelet-derived-growth-factor-receptor-alpha_5a7a2512b73968e4ac5f69e738084264.svg) | N-[4-[(5-Tert-butyl-1,2-oxazol-3-yl)carbamoylamino]phenyl]-5-(1-ethyl-2,2,6,6-tetramethylpiperidin-4-yl)oxypyridine-2-carboxamide | IC50 | 7.7 [1] |
![](https://images.aatbio.com/dataset/ic50/platelet-derived-growth-factor-receptor-alpha_fa164f67dd00f6d2e9f05348b548a4dc.svg) | 4-(6,7-Dimethoxy-4-quinazolinyl)-N-(4-nitrophenyl)-1-piperazinecarboxamide | IC50 | 890.0 [1] |
![](https://images.aatbio.com/dataset/ic50/platelet-derived-growth-factor-receptor-alpha_db1c4101edd4d0e56243e487072e2c2f.svg) | 4-(Chloromethyl)-N-(4-methyl-3-((4-(pyridin-3-yl)pyrimidin-2-yl)amino)phenyl)benzamide | IC50 | 139.0 [1] |
![](https://images.aatbio.com/dataset/ic50/platelet-derived-growth-factor-receptor-alpha_a452f7fd8852df7e5f3343bd9b7cb319.svg) | N-({4-[(6,7-Dimethoxyquinolin-4-Yl)oxy]phenyl}carbamothioyl)-2-Phenylacetamide | IC50 | 28.0 [1] |
![](https://images.aatbio.com/dataset/ic50/platelet-derived-growth-factor-receptor-alpha_95c6fd10c2c39905c8d8d7d4c93a7f9b.svg) | 1-Cyclohexyl-3-[4-(6,7-dimethoxyquinazolin-4-yl)oxyphenyl]urea | IC50 | 7.0 [1] |
![](https://images.aatbio.com/dataset/ic50/platelet-derived-growth-factor-receptor-alpha_c7c31ad92e1b0b77d0138e3a513f200e.svg) | N-Benzyl-4-(6,7-dimethoxyquinazolin-4-yl)piperazine-1-carbothioamide | IC50 | 240.0 [1] |
![](https://images.aatbio.com/dataset/ic50/platelet-derived-growth-factor-receptor-alpha_628e796c331326ac7d59e9f8e229eaa5.svg) | 6,6-Dimethyl-8-[1-(oxan-4-ylmethyl)piperidin-4-yl]-11-oxo-5H-benzo[b]carbazole-3-carbonitrile | IC50 | 402.0 [1] |
![](https://images.aatbio.com/dataset/ic50/platelet-derived-growth-factor-receptor-alpha_2daeae1ba368364e2879bf7f4c41affb.svg) | 1-[4-[4-Amino-7-(1-methylpyrazol-4-yl)thieno[3,2-c]pyridin-3-yl]phenyl]-3-(3-fluorophenyl)urea | Ki | 50.12 [1] |
![](https://images.aatbio.com/dataset/ic50/platelet-derived-growth-factor-receptor-alpha_9dabcb9dd97dc98e9c2238fea0fb3696.svg) | Glycine, N,N-dimethyl-, 2-(1H-indol-2-ylcarbonyl)-1H-indol-5-yl ester | IC50 | 100.0 [1] |
![](https://images.aatbio.com/dataset/ic50/platelet-derived-growth-factor-receptor-alpha_b43f9b172387f2a84cebdafc2497da4c.svg) | cis-3-[4-Amino-7-(3-azetidin-1-ylmethyl-cyclobutyl)-7H-pyrrolo[2,3-d]pyrimidin-5-yl]-phenol | IC50 | 900.0 [1] |
![](https://images.aatbio.com/dataset/ic50/platelet-derived-growth-factor-receptor-alpha_101f274fa0d894c601461fd7747171a3.svg) | 7-[3-(Azetidin-1-ylmethyl)cyclobutyl]-5-[3-[[(2S)-oxolan-2-yl]methoxy]phenyl]pyrrolo[2,3-d]pyrimidin-4-amine | IC50 | 10000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/platelet-derived-growth-factor-receptor-alpha_3e70e51b426b206601dadb33b22bbf88.svg) | 2-Amino-N-[3-[[5-chloro-4-(2-propan-2-ylsulfonylanilino)pyrimidin-2-yl]amino]phenyl]acetamide | IC50 | 1000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/platelet-derived-growth-factor-receptor-alpha_814ad9e264ab2b2e27706d05bd4c2f07.svg) | 4-(6,7-Dimethoxy-quinoxalin-2-ylamino)-cyclohexanol | IC50 | 299.0 [1] |
![](https://images.aatbio.com/dataset/ic50/platelet-derived-growth-factor-receptor-alpha_ff9c97ae965f3c38b1a326d77574c930.svg) | N-(4-Bromophenyl)-4-(6,7-dimethoxyquinazolin-4-yl)piperazine-1-carboxamide | IC50 | 710.0 [1] |
![](https://images.aatbio.com/dataset/ic50/platelet-derived-growth-factor-receptor-alpha_d314a05f0f8d40841f85d577da4a24e4.svg) | N-(4-Cyanophenyl)-4-(6,7-dimethoxyquinazolin-4-yl)piperazine-1-carboxamide | IC50 | 770.0 [1] |
![](https://images.aatbio.com/dataset/ic50/platelet-derived-growth-factor-receptor-alpha_95493f8d18603aa8ebb85025d281548b.svg) | 4-(6,7-Dimethoxyquinazolin-4-yl)-N-(4-propan-2-ylphenyl)piperazine-1-carboxamide | IC50 | 90.0 [1] |
![](https://images.aatbio.com/dataset/ic50/platelet-derived-growth-factor-receptor-alpha_0a2289a52c28727b80ac70b24ea0d60d.svg) | 1-(2,4-Difluoro-phenyl)-3-[4-(6,7-dimethoxy-quinolin-4-yloxy)-3-fluoro-phenyl]-urea | IC50 | 17.0 [1] |
![](https://images.aatbio.com/dataset/ic50/platelet-derived-growth-factor-receptor-alpha_5424b9389bf336c3b239aefdc0548304.svg) | 1-[4-[4-Amino-7-[3-(methylamino)prop-1-ynyl]thieno[3,2-c]pyridin-3-yl]phenyl]-3-(3-methylphenyl)urea | Ki | 2.51 [1] |
![](https://images.aatbio.com/dataset/ic50/platelet-derived-growth-factor-receptor-alpha_c77b2a133979784a97a721be0b7a543d.svg) | Tert-butyl N-[4-[4-amino-1-[2-[4-(dimethylamino)piperidin-1-yl]ethyl]pyrazolo[3,4-d]pyrimidin-3-yl]-2-methoxyphenyl]carbamate | IC50 | 10000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/platelet-derived-growth-factor-receptor-alpha_f64ae507fb96828f441cbfe1c221da9b.svg) | 1-[5-Amino-4-(3,4-dichlorophenyl)-3-methylpyrazol-1-yl]ethanone | IC50 | 100000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/platelet-derived-growth-factor-receptor-alpha_c7c3df679c3f2be78c0d5228a1850316.svg) | N-Ethyl-2-hydroxy-N-methyl-3-[C-phenyl-N-[4-(piperidin-1-ylmethyl)phenyl]carbonimidoyl]-1H-indole-6-carboxamide | IC50 | 890.0 [1] |
![](https://images.aatbio.com/dataset/ic50/platelet-derived-growth-factor-receptor-alpha_17109177bc8eadc6e1f7233f0c39d1eb.svg) | Vegfrecine | IC50 | 3200.0 [1] |
![](https://images.aatbio.com/dataset/ic50/platelet-derived-growth-factor-receptor-alpha_2d6824ed4663109c98dca83443bd727c.svg) | 3-{[(1R)-1-Phenylethyl]amino}-4-(pyridin-4-ylamino)cyclobut-3-ene-1,2-dione | IC50 | 40500.0 [1] |
![](https://images.aatbio.com/dataset/ic50/platelet-derived-growth-factor-receptor-alpha_dbc9774b4a10efc12e4d4309ee79f133.svg) | (13R,15S)-13-Methyl-16-oxa-8,9,12,22,24-pentazahexacyclo[15.6.2.16,9.112,15.02,7.021,25]heptacosa-1(24),2,4,6,17,19,21(25)-heptaene-23,27-dione | IC50 | 1000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/platelet-derived-growth-factor-receptor-alpha_b076cdaba7bb8b7d9a4e8120c86a34a8.svg) | N-Propyl-4-({4-[(2,2,2-trifluoroethyl)amino]-1H-pyrrolo[2,3-d]pyrimidin-2-yl}amino)benzamide | IC50 | 4310.0 [1] |
![](https://images.aatbio.com/dataset/ic50/platelet-derived-growth-factor-receptor-alpha_03030c3391d76728319895cee40337ad.svg) | 1-[4-[4-Amino-7-(3-amino-3-methylbut-1-ynyl)thieno[3,2-c]pyridin-3-yl]phenyl]-3-(3-methylphenyl)urea | Ki | 10000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/platelet-derived-growth-factor-receptor-alpha_c2c108e88edd913b2e1d9ccb5d52969f.svg) | N-(1,3-Dimethylpyrazol-4-yl)-2-[2-methoxy-4-(7-methoxyquinolin-4-yl)oxyphenyl]acetamide | IC50 | 3.0 [1] |
![](https://images.aatbio.com/dataset/ic50/platelet-derived-growth-factor-receptor-alpha_37c7d87ae1e9271852ba4e05a57e8cac.svg) | CID 25207521 | IC50 | 11100.0 [1] |
![](https://images.aatbio.com/dataset/ic50/platelet-derived-growth-factor-receptor-alpha_9c915aff1a2a3548278028f758eb7643.svg) | 6H-Pyrido(4,3-b)carbazol-9-ol, 1-((3-(diethylamino)propyl)amino)-5,6,11-trimethyl-, hydrate | IC50 | 2000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/platelet-derived-growth-factor-receptor-alpha_095f0410fbe6503f911b1ebc7cd80921.svg) | 6-[2-[2-(Dimethylamino)ethylamino]ethylamino]-2-octylbenzo[de]isoquinoline-1,3-dione | IC50 | 100000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/platelet-derived-growth-factor-receptor-alpha_fa6c33f138c388f089aea8586bac748e.svg) | 6-[2-[2-(Dimethylamino)ethylamino]ethylamino]-2-dodecylbenzo[de]isoquinoline-1,3-dione | IC50 | 26170.0 [1] |
![](https://images.aatbio.com/dataset/ic50/platelet-derived-growth-factor-receptor-alpha_9869d4afb98ef2c3ccd6540bb969cfa4.svg) | CID 46864270 | IC50 | 1.3 [1] |
![](https://images.aatbio.com/dataset/ic50/platelet-derived-growth-factor-receptor-alpha_a393d807e71b1e743502e2b63e78a618.svg) | 3-[7-[4-[(1S,4S)-5-Methyl-2,5-diazabicyclo[2.2.1]heptan-2-yl]phenyl]-2-pyridin-4-ylpyrazolo[1,5-a]pyrimidin-3-yl]phenol | IC50 | 6560.0 [1] |